Jennifer Ballantyne

Charlie Caher is a partner in the Firm's Litigation/Controversy Department, and a member of the International Arbitration Practice Group. He joined the Firm in 2008. Mr. Caher is based in the London office, where he practices International Arbitration and English High Court Litigation.

Prior to joining Skadden, Mr. Gal led the strategic development of the Middle Eastern litigation practice of another major U.S. law firm. Over the course of the last 20 years, he has represented some of the world’s leading companies in sectors such as telecommunications, banking and finance, infrastructure, energy, construction and technology under a variety of different rules including ICC, ICSID, LCIA, UNCITRAL, AAA and ad hoc arbitrations. He served, until recently, as one of Austral...

Justin Watts is an experienced patent litigator who has an established and well-regarded intellectual property practice. Clients rely on his industry knowledge and years of experience to handle their complex, multinational disputes. Dr. Watts represents a variety of clients, with an emphasis on those in the pharmaceutical, medical devices, biotechnology, communications, and hardware and software industries, in disputes involving standards, competition law and patents. Dr. Watts' experience en...

Josh Dambacher is a top attorney recognized by Best Lawyers in the practice area(s) of Investment Funds. Josh, who practices law in London, United Kingdom, has been recognized since 2021. This recognition is based on an exhaustive peer-review survey, reflecting the high esteem in which Josh is held by other top lawyers in the same geographic and legal practice area.

Cy Benson is a U.S. and English qualified partner in the London office of Gibson, Dunn & Crutcher and serves as Co-Chair of the firm’s International Arbitration Practice Group. Mr Benson represents clients from a wide variety of sectors before commercial and investment treaty tribunals with particular experience in telecoms, oil & gas, mining and infrastructure disputes. He continues to represent a Dutch and a Luxembourg investor in two separate multi-billion dollar arbitration ...

Deborah Ruff leads Pillsbury’s Arbitration - U.S. & International practice. She has extensive experience in multi-jurisdiction disputes, with a focus on high-value and complex international arbitration in the energy, infrastructure and construction, telecommunications and financial sectors. Deborah conducts international arbitration disputes often over JOAs, the construction of and off-take from refineries and petrochemical plants, as well as rig, energy trading and transport, and c...

Lincoln Tsang is a top attorney recognized by Best Lawyers in the practice area(s) of Life Sciences Law. Lincoln, who practices law in London, United Kingdom, has been recognized since 2024. This recognition is based on an exhaustive peer-review survey, reflecting the high esteem in which Lincoln is held by other top lawyers in the same geographic and legal practice area.

Carolyn Jackson helps clients solve complex cross-border issues involving the regulation of financial institutions and financial products, including derivatives. Carolyn's depth of knowledge and practical approach are shaped by her first-hand experience: she managed the New York trading desk of several investment banks and was formerly the executive director of the International Swaps and Derivatives Association, Inc. Trading firms, banks, asset managers, clearing houses and trading venues re...

Al Gourley is a Partner at the firm’s London office. He is a globally-recognised resource lawyer, having led many UK and Canadian initial public offerings, secondary and alternative finance transactions, as well as mergers and acquisitions, in the resource sector, particularly cross-border transactions involving Europe, Africa, Australia and Canada. Al is also the Chairman of the World Initiative of Mining Lawyers based in Europe. Al is known for his knowledge of “pure” mini...

Tim is a partner in Goodwin’s Technology and Life Sciences groups, based in the Cambridge and London offices.Mr. Worden regularly advises life sciences companies on licensing and partnering deals, R&D agreements, clinical trials agreements, distribution agreements, and a broad spectrum of regulatory matters. His expertise also includes advising on the IP and regulatory aspects of M&A transactions, IPOs and venture capital investments. Outside of the life sciences sector, Mr. Wor...